Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11434302 Bispecific T cell engaging antibody constructs

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Markus Münz0

Matthias Friedrich0

Pamela Bogner0

Patrick Hoffmann0

Peter Kufer0

Tobias Raum0

Benno Rattel0

Cornelius Pompe0

...

Date of Patent

September 6, 2022

0

Patent Application Number

154226470

Date Filed

February 2, 2017

0

Patent Citations

US Patent 10220090 BCMA Antigen binding proteins

US Patent 10301391 BCMA and CD3 bispecific T cell engaging antibody constructs

US Patent 10294300 Antibody constructs for DLL3 and CD3

US Patent 10519241 Antibody constructs for EGFRVIII and CD3

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

The present invention provides bispecific antibody constructs of a specific Fc modality characterized by comprising a first domain binding to a target cell surface antigen, a second domain binding to an extracellular epitope of the human and/or the

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11434302 Bispecific T cell engaging antibody constructs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool